EARNINGS: Shortwave Life Sciences half-year loss widens
30th Jan 2026 22:01
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
| Price | 305.00p on 18-03-2026 at 11:24:53 |
|---|---|
| Change | 0.00p 0% |
| Buy | 308.00p |
| Sell | 302.00p |
| Last Trade: | Unknown 260.00 at 305.00p |
| Day's Volume: | 335 |
| Last Close: | 305.00p |
| Open: | 305.00p |
| ISIN: | GB00B2PP2527 |
| Day's Range | 305.00p - 305.00p |
| 52wk Range: | 242.00p - 316.00p |
| Market Capitalisation: | £286.96m |
| VWAP: | 304.93284p |
| Shares in Issue: | 94.09m |
Sector: Closed End Investments
Ct Global Grwth (CMPG) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 260 | 305.00p | Ordinary |
11:24:52 - 18-Mar-26 |
| Sell* | 75 | 304.70p | Ordinary |
09:15:10 - 18-Mar-26 |
| Sell* | 229 | 304.70p | Ordinary |
14:42:10 - 17-Mar-26 |
| Unknown* | 26,531 | 300.717p | Ordinary |
13:23:04 - 17-Mar-26 |
| Unknown* | 3,914 | 305.00p | Ordinary |
13:22:42 - 17-Mar-26 |
| Sell* | 21 | 302.54p | Ordinary |
12:15:49 - 17-Mar-26 |
| Unknown* | 27,470 | 305.121p | Ordinary |
11:24:53 - 16-Mar-26 |
| Unknown* | 26,131 | 305.00p | Ordinary |
11:24:26 - 16-Mar-26 |
| Sell* | 3,600 | 302.54p | Ordinary |
08:41:25 - 16-Mar-26 |
| Unknown* | 16,045 | 303.294p | Ordinary |
11:24:04 - 13-Mar-26 |
Ct Global Grwth (CMPG) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 17th Mar 2026 12:39 pm | RNS | Net Asset Value(s) |
| 16th Mar 2026 12:31 pm | RNS | Net Asset Value(s) |
| 12th Mar 2026 5:21 pm | RNS | Portfolio Update |
| 10th Mar 2026 12:58 pm | RNS | Net Asset Value(s) |
| 9th Mar 2026 12:44 pm | RNS | Net Asset Value(s) |
| 6th Mar 2026 12:42 pm | RNS | Net Asset Value(s) |
| 6th Mar 2026 12:11 pm | RNS | Portfolio Update |
| 6th Mar 2026 12:10 pm | RNS | Portfolio Update |
| 5th Mar 2026 3:12 pm | RNS | Director/PDMR Shareholding |
| 5th Mar 2026 1:00 pm | RNS | Net Asset Value(s) |